Literature DB >> 11527156

Genetic lesions and perturbation of chromatin architecture: a road to cell transformation.

S Chakraborty1, V Senyuk, G Nucifora.   

Abstract

Differential gene expression is a rigorously precise procedure that defines the developmental program of cells, tissues, organs, and of the entire organism. The correct execution of this program requires the participation of multiple and complex groups of regulators. In addition to transcription factors, which are key tools in ontogenesis by providing sequential switch of different genes, the structure of the chromatin is a dominant determinant leading to gene expression. Through the novel and insightful work of several investigators, it appears that the architecture of the chromatin spanning the genes can and does influence the efficiency of RNA transcription, and therefore of gene expression. Several new enzymatic complexes have been identified that reversibly modify the chromatin architecture by methylation, phosphorylation, and acetylation of the nucleosomal core proteins. These enzymes are crucial for the proper balance and maintenance of gene expression, and are often the target of mutations and alterations in human cancer. Here, we review briefly the current models proposing how some of these enzymes normally modify the chromatin structure and how their functional disruption leads to inappropriate gene expression and cell transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527156     DOI: 10.1002/jcb.1165

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice.

Authors:  Daniel J Ceradini; Dachun Yao; Raymon H Grogan; Matthew J Callaghan; Diane Edelstein; Michael Brownlee; Geoffrey C Gurtner
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

Review 2.  Linking the epigenetic 'language' of covalent histone modifications to cancer.

Authors:  S B Hake; A Xiao; C D Allis
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.